Long-Term Non-Interventional Study (NIS) To Investigate The Safety And Effectiveness Of MACUGEN In Patients With Neovascular Age-Related Macular Degeneration Under Conditions Of Routine Clinical Practice

Pfizer

Status: Completed

Conditions: Age-related Macular Degeneration

Treatments: Other: no intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT00787319

A5751032

Details and patient eligibility

About

To define what procedures were used for the diagnosis and monitoring of the treatment age-related macular degeneration (AMD). What is the effect of the Macugen, compliance with Macugen treatment, safety profile of Macugen, final physician assessment of treatment with Macugen.

Full description

no sampling

Enrollment: 108 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• age over 18 years old
• patients with neovascular age-related macular degeneration
• enrollment to study is fully on physician decision in compliance with current SPC

Exclusion criteria

• Patient who did not meet indication according to SPC Macugen.

Trial design

108 participants in 1 patient group

AMD

Treatment:

Other: no intervention